Insights

Innovative Biomarker Detection Stabilux Biosciences develops advanced bright dye technology capable of detecting previously undetectable and rare biomarkers, making it highly relevant for companies focusing on early disease detection, personalized medicine, and precision diagnostics.

Targeted Market Opportunities Their platform is particularly suited for industries involved in cancer research, immunology, and drug discovery, presenting opportunities to collaborate with biotech and pharmaceutical firms aiming to improve biomarker identification and monitoring.

Growing Research Focus As biomedical research increasingly emphasizes high-throughput biomarker analysis, Stabilux’s proprietary technology positions it as a key supplier for research organizations and clinical laboratories seeking to enhance detection capabilities.

Funding and Development Stage With recent funding of $276K and revenue under $1 million, the company offers prospects for strategic partnerships, investments, or pilot programs as it advances toward commercial scalability and expands its market presence.

Complementary Tech Integration The company’s technology stack and focus on innovative detection methods make it a strong partner for firms developing related diagnostic tools, laboratory automation solutions, or digital health platforms looking to incorporate advanced biomarker detection.

Stabilux Biosciences, Inc. Tech Stack

Stabilux Biosciences, Inc. uses 8 technology products and services including Quantcast Measure, Curalate, Weebly, and more. Explore Stabilux Biosciences, Inc.'s tech stack below.

Quantcast Measure

Analytics

Curalate

Analytics

Weebly

Content Management System

Video.js

Javascript Libraries

jQuery

Javascript Libraries

Hammer.js

Javascript Libraries

PHP

Programming Languages

Quantcast

System Analytics & Monitoring

Stabilux Biosciences, Inc. Email Formats	Example	Percentage
FirstLast@stabiluxbiosciences.com	JohnDoe@stabiluxbiosciences.com	50%
FirstLast@stabiluxbiosciences.com	JohnDoe@stabiluxbiosciences.com	50%

Stabilux Biosciences, Inc. Email Formats

Example

Percentage

FirstLast@stabiluxbiosciences.com

JohnDoe@stabiluxbiosciences.com

50%

FirstLast@stabiluxbiosciences.com

JohnDoe@stabiluxbiosciences.com

50%

Frequently Asked Questions

Where is Stabilux Biosciences, Inc.'s headquarters located?

Stabilux Biosciences, Inc.'s main headquarters is located at 600 South Wagner Road, Ann Arbor, Michigan 48103, US. The company has employees across 2 continents, including North AmericaEurope.

What is Stabilux Biosciences, Inc.'s official website and social media links?

Stabilux Biosciences, Inc.'s official website is stabiluxbiosciences.com and has social profiles on LinkedIn Crunchbase.

What is Stabilux Biosciences, Inc.'s SIC code NAICS code?

Stabilux Biosciences, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Stabilux Biosciences, Inc. have currently?

As of December 2025, Stabilux Biosciences, Inc. has approximately 8 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: S. T.Consultant: M. T.Consutant: X. L.. Explore Stabilux Biosciences, Inc.'s employee directory with LeadIQ.

What industry does Stabilux Biosciences, Inc. belong to?

Stabilux Biosciences, Inc. operates in the Biotechnology Research industry.

What technology does Stabilux Biosciences, Inc. use?

Stabilux Biosciences, Inc.'s tech stack includes Quantcast MeasureCuralateWeeblyVideo.jsjQueryHammer.jsPHPQuantcast.

What is Stabilux Biosciences, Inc.'s email format?

Stabilux Biosciences, Inc.'s email format typically follows the pattern of FirstLast@stabiluxbiosciences.com. Find more Stabilux Biosciences, Inc. email formats with LeadIQ.

How much funding has Stabilux Biosciences, Inc. raised to date?

As of December 2025, Stabilux Biosciences, Inc. has raised $276K in funding. The last funding round occurred on Sep 02, 2020 for $276K.

When was Stabilux Biosciences, Inc. founded?

Stabilux Biosciences, Inc. was founded in 2014.

Stabilux Biosciences, Inc.

Q: How many employees does Stabilux Biosciences, Inc. have currently?

Stabilux Biosciences, Inc. has approximately 8 employees.

Biotechnology ResearchUnited States2-10 Employees

New biomedical discovery is driving the need to find improved methods to identify novel and rare biomarkers. Early cancer detection, drug discovery, mRNA vaccines, immunology all rely on accurate detection of rare biomarkers and measurement of many biomarkers at the same time. After a decade of pioneering materials development at Michigan Technological University, StabiLux Bright Technology is now set to provide a platform that elevates biomedical research by detecting previously undetectable markers.  This includes rapidly identifying markers like troponin released during cardiac arrest and spotting cancer markers in their earliest stages. StabiLux High Brightness Dyes will help discover, detect and monitor these biomarkers and is poised to unleash the next wave of biomedical Innovation.

Insights

Similar companies to Stabilux Biosciences, Inc.

Exelixis

Sarepta Therapeutics

Incyte

Vertex Pharmaceuticals

Alnylam Pharmaceuticals

Biogen

Gilead Sciences

Neurocrine Biosciences

Amgen